These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 24283107)
1. Evaluation of the cost of atrial fibrillation during emergency hospitalization. Pirson M; Di Pierdomenico L; Gusman J; Baré B; Fontaine D; Motte S Acta Cardiol; 2013 Oct; 68(5):469-74. PubMed ID: 24283107 [TBL] [Abstract][Full Text] [Related]
2. Acute treatment of atrial fibrillation: spontaneous conversion rates and cost of care. Dell'Orfano JT; Patel H; Wolbrette DL; Luck JC; Naccarelli GV Am J Cardiol; 1999 Mar; 83(5):788-90, A10. PubMed ID: 10080441 [TBL] [Abstract][Full Text] [Related]
3. Summaries for patients. Cost-effectiveness of rate control vs. rhythm control for patients with atrial fibrillation. Ann Intern Med; 2004 Nov; 141(9):I20. PubMed ID: 15520416 [No Abstract] [Full Text] [Related]
4. Cost-effectiveness of rhythm versus rate control in atrial fibrillation. Marshall DA; Levy AR; Vidaillet H; Fenwick E; Slee A; Blackhouse G; Greene HL; Wyse DG; Nichol G; O'Brien BJ; Ann Intern Med; 2004 Nov; 141(9):653-61. PubMed ID: 15520421 [TBL] [Abstract][Full Text] [Related]
5. The costs of care in atrial fibrillation and the effect of treatment modalities in Germany. McBride D; Mattenklotz AM; Willich SN; Brüggenjürgen B Value Health; 2009; 12(2):293-301. PubMed ID: 18657103 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of therapies for patients with nonvalvular atrial fibrillation. Eckman MH; Falk RH; Pauker SG Arch Intern Med; 1998 Aug 10-24; 158(15):1669-77. PubMed ID: 9701102 [TBL] [Abstract][Full Text] [Related]
7. Impact of a Multidisciplinary Treatment Pathway for Atrial Fibrillation in the Emergency Department on Hospital Admissions and Length of Stay: Results of a Multi-Center Study. Ptaszek LM; Baugh CW; Lubitz SA; Ruskin JN; Ha G; Forsch M; DeOliveira SA; Baig S; Heist EK; Wasfy JH; Brown DF; Biddinger PD; Raja AS; Scirica B; White BA; Mansour M J Am Heart Assoc; 2019 Sep; 8(18):e012656. PubMed ID: 31510841 [TBL] [Abstract][Full Text] [Related]
8. Clinical and cost comparison of ibutilide and direct-current cardioversion for atrial fibrillation and flutter. Murdock DK; Schumock GT; Kaliebe J; Olson K; Guenette AJ Am J Cardiol; 2000 Feb; 85(4):503-6, A11. PubMed ID: 10728961 [TBL] [Abstract][Full Text] [Related]
9. Cost-effective strategies in the acute management of atrial fibrillation. Dell'Orfano JT; Kramer RK; Naccarelli GV Curr Opin Cardiol; 2000 Jan; 15(1):23-8. PubMed ID: 10666658 [TBL] [Abstract][Full Text] [Related]
10. Daily costs of hospitalization in non-valvular atrial fibrillation patients treated with anticoagulant therapy. Dasta JF; Pilon D; Mody SH; Lopatto J; Laliberté F; Germain G; Bookhart BK; Lefebvre P; Nutescu EA J Med Econ; 2015; 18(12):1041-9. PubMed ID: 26201251 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of cardioversion and antiarrhythmic therapy in nonvalvular atrial fibrillation. Catherwood E; Fitzpatrick WD; Greenberg ML; Holzberger PT; Malenka DJ; Gerling BR; Birkmeyer JD Ann Intern Med; 1999 Apr; 130(8):625-36. PubMed ID: 10215558 [TBL] [Abstract][Full Text] [Related]
12. The burden of atrial fibrillation on the hospital sector in Canada. O'Reilly DJ; Hopkins RB; Healey JS; Dorian P; Sauriol L; Tarride JE; Burke N; Goeree RA Can J Cardiol; 2013 Feb; 29(2):229-35. PubMed ID: 22652091 [TBL] [Abstract][Full Text] [Related]
13. Burden of stroke and other cardiovascular complications in patients with atrial fibrillation hospitalized in France. Cotté FE; Chaize G; Gaudin AF; Samson A; Vainchtock A; Fauchier L Europace; 2016 Apr; 18(4):501-7. PubMed ID: 26718532 [TBL] [Abstract][Full Text] [Related]
14. Cost of hospital admission for antiarrhythmic drug initiation in atrial fibrillation. Kim MH; Klingman D; Lin J; Pathak P; Battleman DS Ann Pharmacother; 2009 May; 43(5):840-8. PubMed ID: 19417111 [TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness and Clinical Effectiveness of the Risk Factor Management Clinic in Atrial Fibrillation: The CENT Study. Pathak RK; Evans M; Middeldorp ME; Mahajan R; Mehta AB; Meredith M; Twomey D; Wong CX; Hendriks JML; Abhayaratna WP; Kalman JM; Lau DH; Sanders P JACC Clin Electrophysiol; 2017 May; 3(5):436-447. PubMed ID: 29759599 [TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of amiodarone for prophylaxis of atrial fibrillation after cardiothoracic surgery. Gillespie EL; White CM; Kluger J; Rancourt JA; Gallagher R; Coleman CI Pharmacotherapy; 2006 Apr; 26(4):499-504. PubMed ID: 16553508 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness and costs of chemical versus electrical cardioversion of atrial fibrillation. de Paola AA; Figueiredo E; Sesso R; Veloso HH; Nascimento LO; Int J Cardiol; 2003 Apr; 88(2-3):157-66. PubMed ID: 12714194 [TBL] [Abstract][Full Text] [Related]
18. The epidemiology and management of recent-onset atrial fibrillation and flutter presenting to the Emergency Department. Hamilton A; Clark D; Gray A; Cragg A; Grubb N; Eur J Emerg Med; 2015 Jun; 22(3):155-61. PubMed ID: 25203594 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of targeting patients undergoing cardiac surgery for therapy with intravenous amiodarone to prevent atrial fibrillation. Mahoney EM; Thompson TD; Veledar E; Williams J; Weintraub WS J Am Coll Cardiol; 2002 Aug; 40(4):737-45. PubMed ID: 12204505 [TBL] [Abstract][Full Text] [Related]
20. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Coyne KS; Paramore C; Grandy S; Mercader M; Reynolds M; Zimetbaum P Value Health; 2006; 9(5):348-56. PubMed ID: 16961553 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]